<?xml version="1.0" encoding="UTF-8" ?>
<?xml-stylesheet type="text/xsl" href="http://cs.bloodhorse.com/utility/FeedStylesheets/rss.xsl" media="screen"?><rss version="2.0" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:slash="http://purl.org/rss/1.0/modules/slash/" xmlns:wfw="http://wellformedweb.org/CommentAPI/"><channel><title>Cutting Through the Briars - by Eric Mitchell</title><link>http://cs.bloodhorse.com/blogs/wgoh/archive/2016/03/21/cutting-through-the-briars-by-eric-mitchell.aspx</link><description>In our previous column we discussed how the Racing Medication &amp; Testing Consortium determines the regulatory thresholds for therapeutic drugs. We looked at this process because the National Horsemen’s Benevolent and Protective Association at its recent</description><dc:language>en</dc:language><generator>CommunityServer 2007.1 (Build: 20917.1142)</generator></channel></rss>